Amanote Research
Register
Sign In
Pioglitazone Time-Dependently Reduces Tumour Necrosis Factor-Α Level in Muscle and Improves Metabolic Abnormalities in Wistar Fatty Rats
Diabetologia
- Germany
doi 10.1007/s001250050901
Full Text
Open PDF
Abstract
Available in
full text
Categories
Internal Medicine
Endocrinology
Metabolism
Diabetes
Date
February 16, 1998
Authors
K. Murase
H. Odaka
M. Suzuki
N. Tayuki
H. Ikeda
Publisher
Springer Science and Business Media LLC
Related search
Dietary Fat Modifies Some Metabolic Actions of Human Recombinant Tumour Necrosis Factor Α in Rats
British Journal of Nutrition
Medicine
Nutrition
Dietetics
E0154 Expression of Tumour Necrosis Factor- Converting Enzyme and Tumour Necrosis Factor- In Rats With Alcoholic Cardiomyopathy
Heart
Cardiovascular Medicine
Cardiology
Tumour Necrosis Factor-Α Production and Immune Cell Activation in Tuberculous Meningitis
Mediators of Inflammation
Immunology
Cell Biology
Activated Macrophages Promote WNT Signalling Through Tumour Necrosis Factor-Α in Gastric Tumour Cells
EMBO Journal
Immunology
Molecular Biology
Biochemistry
Microbiology
Neuroscience
Medicine
Genetics
Crystallization and Preliminary X-Ray Analysis of the Tumour Necrosis Factor Α–tumour Necrosis Factor Receptor Type 2 Complex
Acta Crystallographica Section F Structural Biology and Crystallization Communications
Metabolic Abnormalities in Tumour Bearing Animals
British Journal of Cancer
Cancer Research
Oncology
Rac1 Activation Induces Tumour Necrosis Factor-Α Expression and Cardiac Dysfunction in Endotoxemia
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Tumor Necrosis Factor- Antagonism Improves Vasodilation During Hyperinsulinemia in Metabolic Syndrome
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
ADAM28 Is Elevated in Humans With the Metabolic Syndrome and Is a Novel Sheddase of Human Tumour Necrosis Factor-Α
Immunology and Cell Biology
Allergy
Immunology
Cell Biology